New heart device put to the test in first human study
NCT ID NCT06840509
First seen Feb 21, 2026 · Last updated Jun 15, 2026 · Updated 13 times
Summary
This study tests a new implantable defibrillator (CorSky ICD) in 52 people who need one to control dangerous heart rhythms or heart failure. The device delivers a shock to restore normal rhythm and is checked over 12 months for safety and performance. Participants visit the clinic several times to ensure the device works correctly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Alexandra Hospital
Brisbane, Australia
Conditions
Explore the condition pages connected to this study.